[The benefit of pioglitazone in patients with diabetes mellitus type 2 and cardiovascular complications].
Olsovský
J
J
Diabetologické centrum II. interní kliniky Lékarské fakulty MU a FN u sv. Anny, Brno. jindrich.olsovsky@fnusa.cz
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone